Medartis Holding AG/Fr. MED
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Medartis Holding AG
Medartis Holding AG is a Swiss company operating in the medical technology industry, primarily focused on the development, manufacturing, and distribution of orthopedic surgical implants. The company's core products include precision implant systems for surgical fixation of bone fractures and osteotomies, particularly in the areas of the head, hand, wrist, foot, and ankle. Founded in 1997 and headquartered in Basel, Switzerland, Medartis has established a presence in key international markets across Europe, the Americas, and Asia-Pacific. The company's strategic positioning emphasizes innovation in implant technology, aiming for high standards of surgical precision and patient recovery outcomes.
Ticker
Fr. MED
Sector
Primary listing
XSWX
Employees
1,259
Headquarters
Basel, Switzerland
Website
MED Metrics
BasicAdvanced
CHF 1B
119.70
CHF 0.67
1.26
-
Price and volume
Market cap
CHF 1B
Beta
1.26
52-week high
CHF 97.50
52-week low
CHF 61.00
Average daily volume
5.5K
Financial strength
Current ratio
2.215
Quick ratio
1.065
Long term debt to equity
47.683
Total debt to equity
57.316
Interest coverage (TTM)
0.38%
Profitability
EBITDA (TTM)
19.57
Gross margin (TTM)
75.89%
Net profit margin (TTM)
3.10%
Operating margin (TTM)
1.06%
Effective tax rate (TTM)
27.00%
Revenue per employee (TTM)
CHF 210,000
Management effectiveness
Return on assets (TTM)
0.35%
Return on equity (TTM)
3.42%
Valuation
Price to earnings (TTM)
119.702
Price to revenue (TTM)
3.697
Price to book
3.68
Price to tangible book (TTM)
21.62
Price to free cash flow (TTM)
106.563
Free cash flow yield (TTM)
0.94%
Free cash flow per share (TTM)
0.753
Growth
Revenue change (TTM)
19.76%
Earnings per share change (TTM)
139.29%
3-year revenue growth (CAGR)
13.77%
10-year revenue growth (CAGR)
12.58%
3-year earnings per share growth (CAGR)
11.09%
10-year earnings per share growth (CAGR)
-5.95%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medartis Holding AG stock?
Medartis Holding AG (MED) has a market cap of Fr.1B as of April 07, 2026.
What is the P/E ratio for Medartis Holding AG stock?
The price to earnings (P/E) ratio for Medartis Holding AG (MED) stock is 119.7 as of April 07, 2026.
Does Medartis Holding AG stock pay dividends?
No, Medartis Holding AG (MED) stock does not pay dividends to its shareholders as of April 07, 2026.
When is the next Medartis Holding AG dividend payment date?
Medartis Holding AG (MED) stock does not pay dividends to its shareholders.
What is the beta indicator for Medartis Holding AG?
Medartis Holding AG (MED) has a beta rating of 1.26. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.